170 related articles for article (PubMed ID: 29903421)
21. Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control study.
Kaya A; Kaya SY; Balkan II; Bayramlar OF; Mete B; Saltoglu N; Aygün G; Tabak ÖF
Wien Klin Wochenschr; 2021 May; 133(9-10):478-483. PubMed ID: 32910333
[TBL] [Abstract][Full Text] [Related]
22. Laboratory-identified vancomycin-resistant enterococci bacteremia incidence: A standardized infection ratio prediction model.
Tanwar SSS; Weiner-Lastinger LM; Bell JM; Allen-Bridson K; Bagchi S; Dudeck MA; Edwards JR
Infect Control Hosp Epidemiol; 2022 Jun; 43(6):714-718. PubMed ID: 34085620
[TBL] [Abstract][Full Text] [Related]
23. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
Lautenbach E; Bilker WB; Brennan PJ
Infect Control Hosp Epidemiol; 1999 May; 20(5):318-23. PubMed ID: 10349947
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
Zaas AK; Song X; Tucker P; Perl TM
Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
[TBL] [Abstract][Full Text] [Related]
25. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
Salgado CD
Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
[TBL] [Abstract][Full Text] [Related]
26. Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.
da Silva NS; Muniz VD; Estofolete CF; Furtado GH; Rubio FG
Am J Infect Control; 2014 Apr; 42(4):389-92. PubMed ID: 24679566
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.
Furtado GH; Mendes RE; Pignatari AC; Wey SB; Medeiros EA
Am J Infect Control; 2006 Sep; 34(7):447-51. PubMed ID: 16945692
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution.
Tokars JI; Satake S; Rimland D; Carson L; Miller ER; Killum E; Sinkowitz-Cochran RL; Arduino MJ; Tenover FC; Marston B; Jarvis WR
Infect Control Hosp Epidemiol; 1999 Mar; 20(3):171-5. PubMed ID: 10100542
[TBL] [Abstract][Full Text] [Related]
29. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Patel R; Gallagher JC
Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
[TBL] [Abstract][Full Text] [Related]
30. Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
Stosor V; Peterson LR; Postelnick M; Noskin GA
Arch Intern Med; 1998 Mar; 158(5):522-7. PubMed ID: 9508230
[TBL] [Abstract][Full Text] [Related]
31. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
[TBL] [Abstract][Full Text] [Related]
33. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
Matar MJ; Tarrand J; Raad I; Rolston KV
Am J Infect Control; 2006 Oct; 34(8):534-6. PubMed ID: 17015161
[TBL] [Abstract][Full Text] [Related]
34. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
Santayana EM; Grim SA; Janda WM; Layden JE; Lee TA; Clark NM
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):39-42. PubMed ID: 22749382
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
Lodise TP; McKinnon PS; Tam VH; Rybak MJ
Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
[TBL] [Abstract][Full Text] [Related]
37. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia.
Price CS; Paule S; Noskin GA; Peterson LR
Clin Infect Dis; 2003 Oct; 37(7):921-8. PubMed ID: 13130403
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older.
Mathis B; Haïne M; Girard R; Bonnefoy M
BMC Geriatr; 2019 Dec; 19(1):377. PubMed ID: 31881861
[TBL] [Abstract][Full Text] [Related]
39. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.
Carmeli Y; Samore MH; Huskins C
Arch Intern Med; 1999 Nov; 159(20):2461-8. PubMed ID: 10665895
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
Kohler P; Eshaghi A; Kim HC; Plevneshi A; Green K; Willey BM; McGeer A; Patel SN;
PLoS One; 2018; 13(3):e0193926. PubMed ID: 29566004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
